Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01518725 · ClinicalTrials.gov registry record · Phase 4
The Effect of Vitamin D Supplementation on Muscle Power in Elite Cyclist
A Phase 4 study of Muscle Power, sponsored by Oklahoma State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT01518725: Completed Phase 4 study of Muscle Power, sponsored by Oklahoma State University.
NCT01518725 is a Phase 4 study of Muscle Power that has completed, run by Oklahoma State University. The registered enrollment target is 103 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01518725, a Phase 4 study of Muscle Power, has completed, sponsored by Oklahoma State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the change in vitamin D status with the change in muscular strength and muscular power in highly trained athletes over a 9-month study period. The investigators hypothesize that the greatest muscular strength and power gains will be demonstrated in the athletes who achieve and maintain a 25(OH)-D \> 50 ng/mL (but \< 100 ng/mL) over the 6 month study duration. This hypothesis will be tested by carrying out the following specific aims: Aim 1. to determine the extent to which increasing serum 25(OH)D to \> 50 ng/mL is associated with improved muscular power by assessing specific performance measures (e.g. Vertical Jump Test and Wingate test) relative to lean body mass; and Aim 2. to examine the correlation between vitamin D status and muscular power over time.
Primary Outcome
Non fasting blood samples will be used for the evaluation of vitamin D metabolites. Venous blood (\~5 cc) will be collected from the non-dominant arm by a trained phlebotomist, centrifuged at 2,000 rpm and serum stored at -80° C. Two vitamin D metabolites, 25 (OH) D and 1,25 (OH)2 D and serum PTH will be assessed.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Vitamin D
Study Locations (1)
Oklahoma
- Oklahoma State University - Stillwater
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-08 |
| Phase | Phase 4 |
What the finished NCT01518725 record still lists
NCT01518725 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Muscle Power appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01518725 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01518725 about?
NCT01518725 is a clinical study titled "The Effect of Vitamin D Supplementation on Muscle Power in Elite Cyclist". The purpose of this study is to evaluate the change in vitamin D status with the change in muscular strength and muscular power in highly trained athletes over a 9-month study period. The investigators hypothesize that the greatest muscular strength and power gains will be demonstrated in the athlet...
What is the current status of trial NCT01518725?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 103 participants. The study started on 2012-01. Estimated completion is 2013-08.
What conditions does trial NCT01518725 study?
This clinical trial studies the following conditions: Muscle Power.
What interventions are being tested in trial NCT01518725?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01518725?
This trial is sponsored by Oklahoma State University, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01518725 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01518725's enrollment target sits among peer trials
103 760th of 2000 higher than 1,237 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia